In another trial, patients who reduced their Zepbound dose to a lower 5 mg maintenance dose also preserved much of their earlier weight reduction compared with those who stopped treatment entirely
Maybe a slight dip in hunger, maybe not
On average, volunteers in the retatrutide clinical trial who received the study drug rather than a placebo lost an average of 70.3 pounds over about a year-and-a-half, with more than 45% of participants losing more than 30% of their body weight
Knowing which drugs carry the weight-loss indication matters because it affects insurance coverage, manufacturer savings card eligibility, and which treatment plan your healthcare provider can prescribe
Note: Many people trapped in advertisements are getting attracted to these GLP-1 patches
Like semaglutide and tirzepatide, it is a glucagon-like peptide-1 (GLP-1) agonist, meaning it acts on GLP-1 receptors just like the natural GLP-1 hormone in your body